Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$401,330
+$191,341 QoQ
Shares Held
4,711
+47.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#327
of 477 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 27%
Shared 0%
None 73%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sanctuary Advisors, LLC holds $76,467,110 across 63 Biotechnology names. CYTK ranks #28 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
39,923 | $24,893,587 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
39,811 | $19,775,318 | |
| 3 | EXEL |
Exelixis, Inc.
|
41,660 | $2,266,720 | |
| 4 | ARGX |
Argenx SE
|
2,186 | $2,028,105 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
106,632 | $1,995,084 | |
| 6 | INCY |
Incyte Corp
|
15,733 | $1,783,492 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
20,830 | $1,697,853 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
19,611 | $1,534,952 |
All Filings in CYTK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $401,330 | 4,711 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $209,989 | 3,186 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $237,703 | 3,741 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||